RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bellevue, WA · Tacoma, WA · Vancouver, WA · +57 more sites
Ulcerative Colitis clinical trials in Tacoma, WA
15 recruiting ulcerative colitis studies with a site in Tacoma, WA.
RecruitingPhase 3NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Tacoma, WA · +23 more sites
RecruitingPhase 3NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Sponsor: Takeda
Tacoma, WA · +12 more sites
RecruitingPhase 2NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Sponsor: Eli Lilly and Company
Seattle, WA · Spokane, WA · +49 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
Tacoma, WA · +36 more sites
RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Seattle, WA · Tacoma, WA · +24 more sites
RecruitingPhase 3NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Sponsor: Merck Sharp & Dohme LLC
Tacoma, WA · +11 more sites
RecruitingPhase 2NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Palisade Bio
Bellevue, WA · Tacoma, WA · +28 more sites
RecruitingPhase 3NCT07196748
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Tacoma, WA · +55 more sites
RecruitingPhase 2 / Phase 3NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Sponsor: Bristol-Myers Squibb
Seattle, WA · Tacoma, WA · +33 more sites
RecruitingPhase 4NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Sponsor: Takeda
Tacoma, WA · +36 more sites
RecruitingPhase 2NCT06636656
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Sponsor: Boehringer Ingelheim
Seattle, WA · Tacoma, WA · +12 more sites
RecruitingPhase 3NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Sponsor: Takeda
Tacoma, WA · +13 more sites
RecruitingPhase not listedNCT06398626
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Sponsor: Pfizer
Tacoma, WA · +27 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Bellevue, WA · Silverdale, WA · Tacoma, WA · +43 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.